Assisted Conception · UK public procurement notice

CPV: In vitro fertilisation services

Procedure method

Award procedure without prior publication of a call for competition

Legal basis

CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)

Procurement category

Services

Notice status

Awarded without competition

Procurement threshold

Unspecified in notice

Regulatory regime

Standard

Commercial structure

Stand-alone contract (no framework)

Competition type

Direct award (no call for competition)

GPA / WTO covered

Yes (GPA)

Recurring procurement

Unspecified in notice

First published

1 Oct 2025, 15:28 BST

Last source update

1 Oct 2025, 15:28 BST

Authority reference

Assisted Conception - April 24 - Care Fertility QXU Independent

FTS notice number

2025/S 000-061424

Classification (CPV)

In vitro fertilisation services

Delivery area

South East (UKJ25)

Official registry OCID

ocds-h6vhtk-05a61d Find a Tender

Why no open competition

The procurement falls outside the scope of application of the directive

Published justification

This is a Provider Selection Regime (PSR) contract award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 and the Procurement Act 2023 do not apply to this award.

Publisher note: This contract is awarded via Direct Award Process C, in accordance with The Health Care Services (Provider Selection Regime) Regulations 2023 (PSR). The authority confirms the provider delivered the prior contract to a consistently high standard and no material changes have been made in the renewed contracting arrangement. Against the Provider Selection Regime (PSR) Key Criteria, Care Fertility Woking Ltd has demonstrated expertise and is anticipated to continue doing so. Evidence of current service delivery against the PSR Key Criteria and the breakdown of Key Criteria weighting in relation to this service for the purposes of awarding a contract under Direct Award C is detailed below: Quality & Innovation (25%) Quality • The provider has consistently delivered high clinical outcomes, including success rates for IVF and ICSI that meet or exceed national benchmarks. • Most recent CQC ratings in 2023 and internal audits confirm safe, effective, and patient-centred care. • Patient feedback and satisfaction scores are high, especially regarding emotional support from staff, communication and continuity of care. Innovation • The provider uses cutting-edge techniques such as time-lapse embryo imaging and AI-based embryo selection. • They participate in clinical trials and research, contributing to national fertility knowledge. • Patient experience is enhanced through digital platforms, personalised treatment plans, and treatment companion app Salve. Integration, Collaboration & Sustainability (20%) • The provider works closely with local Trusts, primary care, gynaecology, and mental health services, ensuring seamless referral pathways. • There is data-sharing and interoperability with NHS systems, supporting continuity and safeguarding. • The service contributes to the local fertility strategy and aligns with ICS priorities. Improving access, reducing health inequalities and facilitating choice (20%) • The provider offers equitable access, including support for LGBTQ+ families, single parents, and those requiring donor gametes. • Clinics are located within reasonable travel distance or offer virtual consultations for initial assessments. • Waiting times are within NHS targets, and the provider has capacity to meet demand without delays. • The provider holds virtual events and webinars for patients to support education and understanding of the services Value (25%) • The service operates on an activity-based pricing, ensuring cost-effectiveness. • The provider offers bundled pricing for multi-cycle treatments and has demonstrated efficiency in resource use. • The provider has a strong record on staff retention and satisfaction, reducing turnover and improving continuity of care. Social Value (10%) • The provider employs local clinical and administrative staff, contributing to job creation. • They partner with local suppliers for medical consumables and support services, aligning with NHS anchor institution principles. • The clinic has implemented green initiatives, such as: o Low-energy lab equipment o Digital patient records to reduce paper use • They are aligned with the NHS Net Zero Supplier Roadmap, meeting 2025 carbon reduction milestones. • Partnering with Nature's SAFE to support the development of their biobank through a £5,000 donation and by repurposing a state-of-the-art Geri® time-lapse incubator for their groundbreaking work. Governance and Decision-Making Approval: NHS Surrey Heartlands ICB Commissioning, Contracting & Commercial (CCC) Committee Executive Board Conflicts of Interest: No conflicts of interest were identified. Standstill Period and Regulatory Context: This is a Provider Selection Regime (PSR) contract award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 and the Procurement Act 2023 do not apply to this award. Written representations should be sent to [email protected]

• Care Fertility Woking LimitedAwarded supplierGB-NHS: DXC10 5 Hill View Rd, Woking, South East, GU22 7HW

No document links were published on the notice.